293 related articles for article (PubMed ID: 23224339)
1. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.
Agnihotri S; Burrell KE; Wolf A; Jalali S; Hawkins C; Rutka JT; Zadeh G
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):25-41. PubMed ID: 23224339
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Reardon DA; Wen PY
Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI; McNeill KA; Fine HA
Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
[TBL] [Abstract][Full Text] [Related]
4. The challenges associated with molecular targeted therapies for glioblastoma.
Jue TR; McDonald KL
J Neurooncol; 2016 May; 127(3):427-34. PubMed ID: 26900075
[TBL] [Abstract][Full Text] [Related]
5. New molecularly targeted therapies for glioblastoma multiforme.
Polivka J; Polivka J; Rohan V; Topolcan O; Ferda J
Anticancer Res; 2012 Jul; 32(7):2935-46. PubMed ID: 22753758
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapies in glioblastoma multiforme.
McNamara MG; Mason WP
Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
8. On the Concepts and History of Glioblastoma Multiforme - Morphology, Genetics and Epigenetics.
Stoyanov GS; Dzhenkov DL
Folia Med (Plovdiv); 2018 Mar; 60(1):48-66. PubMed ID: 29668458
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma: molecular analysis and clinical implications.
Huse JT; Holland E; DeAngelis LM
Annu Rev Med; 2013; 64():59-70. PubMed ID: 23043492
[TBL] [Abstract][Full Text] [Related]
10. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine.
Sharma HS; Muresanu DF; Castellani RJ; Nozari A; Lafuente JV; Tian ZR; Sahib S; Bryukhovetskiy I; Bryukhovetskiy A; Buzoianu AD; Patnaik R; Wiklund L; Sharma A
Int Rev Neurobiol; 2020; 151():1-66. PubMed ID: 32448602
[TBL] [Abstract][Full Text] [Related]
12. Delivery systems and molecular targets of mechanism-based therapies for GBM.
Phuphanich S; Brat DJ; Olson JJ
Expert Rev Neurother; 2004 Jul; 4(4):649-63. PubMed ID: 15853584
[TBL] [Abstract][Full Text] [Related]
13. Translating biology into clinic: the case of glioblastoma.
Lino M; Merlo A
Curr Opin Cell Biol; 2009 Apr; 21(2):311-6. PubMed ID: 19217766
[TBL] [Abstract][Full Text] [Related]
14. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
[TBL] [Abstract][Full Text] [Related]
15. Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development.
Thaker NG; Zhang F; McDonald PR; Shun TY; Lazo JS; Pollack IF
Neurosurg Focus; 2010 Jan; 28(1):E4. PubMed ID: 20043719
[TBL] [Abstract][Full Text] [Related]
16. For the next trick: new discoveries in radiobiology applied to glioblastoma.
Debus J; Abdollahi A
Am Soc Clin Oncol Educ Book; 2014; ():e95-9. PubMed ID: 24857153
[TBL] [Abstract][Full Text] [Related]
17. Toward precision medicine in glioblastoma: the promise and the challenges.
Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM
Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816
[TBL] [Abstract][Full Text] [Related]
18. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract][Full Text] [Related]
19. Designer therapies for glioblastoma multiforme.
Sathornsumetee S; Rich JN
Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma: from molecular pathology to targeted treatment.
Cloughesy TF; Cavenee WK; Mischel PS
Annu Rev Pathol; 2014; 9():1-25. PubMed ID: 23937436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
